Lecanemab: turning point, or status quo? An ethics perspective
2023; Oxford University Press; Volume: 146; Issue: 9 Linguagem: Inglês
10.1093/brain/awad094
ISSN1460-2156
Autores Tópico(s)Healthcare Decision-Making and Restraints
ResumoJournal Article Lecanemab: turning point, or status quo? An ethics perspective Get access Timothy Daly Timothy Daly Science Norms Democracy UMR 8011, Sorbonne Universite, 75005 Paris, FranceBioethics Program, FLACSO Argentina, Buenos Aires, C1050 AAN, Argentina Correspondence to: Timothy Daly, PhD Science Norms Democracy UMR 8011, Sorbonne Université 1 Rue Victor Cousin 75005, Paris, France E-mail: tdaly@flacso.org.ar https://orcid.org/0000-0003-1650-242X Search for other works by this author on: Oxford Academic PubMed Google Scholar Brain, Volume 146, Issue 9, September 2023, Pages e71–e72, https://doi.org/10.1093/brain/awad094 Published: 21 March 2023 Article history Received: 19 February 2023 Accepted: 16 March 2023 Published: 21 March 2023 Corrected and typeset: 18 April 2023
Referência(s)